ZA929903B - 3(2H)-pyridazinone derivatives and process for the preparation thereof. - Google Patents

3(2H)-pyridazinone derivatives and process for the preparation thereof.

Info

Publication number
ZA929903B
ZA929903B ZA929903A ZA929903A ZA929903B ZA 929903 B ZA929903 B ZA 929903B ZA 929903 A ZA929903 A ZA 929903A ZA 929903 A ZA929903 A ZA 929903A ZA 929903 B ZA929903 B ZA 929903B
Authority
ZA
South Africa
Prior art keywords
preparation
pyridazinone derivatives
pyridazinone
derivatives
Prior art date
Application number
ZA929903A
Other languages
English (en)
Inventor
Peter Dr Chem Matyus
Klara Chem Czako
Ildiko Chem Eng Varga
Andrea Pharm Jednakovics
Agnes Dr Papp
Ilona Dr Bodi
Gyoergy Dr Rablockzky
Andras Dr Varro
Laszlo Dr Jaszlits
Aniko Dr Miklos
Szalay Luca Chem Levay
Gyoergy Schmidt
Marton Dr Phys Fekete
Maria Biol Kuerthy
Katalin Dr Szemeredi
Kaczian Zara Dr Erzsebet
Original Assignee
Egyt Gyogyszervegyeszeti Gyar
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Egyt Gyogyszervegyeszeti Gyar filed Critical Egyt Gyogyszervegyeszeti Gyar
Publication of ZA929903B publication Critical patent/ZA929903B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D237/14—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
ZA929903A 1991-12-20 1992-12-21 3(2H)-pyridazinone derivatives and process for the preparation thereof. ZA929903B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU914057A HU214320B (hu) 1991-12-20 1991-12-20 Eljárás új 3(2H)-piridazinon-származékok és ezeket tartalmazó gyógyszerkészítmények előállítására

Publications (1)

Publication Number Publication Date
ZA929903B true ZA929903B (en) 1993-06-24

Family

ID=10966710

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA929903A ZA929903B (en) 1991-12-20 1992-12-21 3(2H)-pyridazinone derivatives and process for the preparation thereof.

Country Status (22)

Country Link
US (1) US5395934A (el)
JP (1) JP3165935B2 (el)
KR (1) KR100234596B1 (el)
CN (1) CN1088578A (el)
AT (1) AT403282B (el)
BE (1) BE1006223A4 (el)
CA (1) CA2085796C (el)
CH (1) CH684754A5 (el)
CZ (1) CZ286039B6 (el)
DE (1) DE4243381B4 (el)
DK (1) DK152892A (el)
ES (1) ES2108595B1 (el)
FI (1) FI106374B (el)
FR (1) FR2685329B1 (el)
GB (1) GB2262526B (el)
GR (1) GR1002281B (el)
HU (1) HU214320B (el)
NL (1) NL194966C (el)
PL (1) PL172933B1 (el)
RU (1) RU2130019C1 (el)
YU (1) YU48973B (el)
ZA (1) ZA929903B (el)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5969017A (en) * 1996-10-31 1999-10-19 Merck & Co., Inc. Methods of treating or preventing cardiac arrhythmia
US5935945A (en) * 1996-10-31 1999-08-10 Merck & Co., Inc. Methods of treating or preventing cardiac arrhythmia
EP1082309B1 (en) 1998-06-05 2005-09-14 Egis Gyogyszergyar Process for the preparation of a 3(2h)-pyridazinone- 4-substituted amino- 5-chloro- derivative
ES2162731B1 (es) * 1999-06-04 2003-02-16 Faes Fabrica Espanola De Produ Nuevas arilpiperacilnilalquil-3(2h)-piridacinonas.
AU1592301A (en) * 1999-11-11 2001-06-06 Fred Hutchinson Cancer Research Center Novel topoisomerase poisons for the treatment of proliferative disorders
US7173063B1 (en) 2000-11-10 2007-02-06 Fred Hutchinson Cancer Research Center Topoisomerase poisons for the treatment of proliferative disorders
HUP0103064A3 (en) * 2001-07-26 2005-06-28 Egis Gyogyszergyar Nyilvanosan Polymorphic form of 5-chloro-4-(3-{[2-(3,4-dimethoxy-phenyl)-ethyl]-methyl-amino]-propylamino)-3-(2h)-piridazinone fumarate, its use, process for its preparation and pharmaceutical compositions containing it
HU227237B1 (en) * 2001-09-27 2010-12-28 Egis Gyogyszergyar Nyilvanosan Muekoedoe Reszvenytarsasag Substituted alkylpyridazinone derivatives, process for their preparation, pharmaceutical compositions containing them
EP1470112A1 (en) * 2002-01-18 2004-10-27 Pharmacia Corporation Substituted pyridazinones as inhibitors of p38
HU227181B1 (en) * 2002-09-11 2010-09-28 Egis Gyogyszergyar Nyilvanosan Use of 5-chloro-4-[3-[n-[2-(3,4-dimethoxyphenyl)ethyl)]-n-methylamino]-propylamino]-3-(2h)-pyridazinone for producing pharmaceutical compositions having metabolic modulator effect
US9034850B2 (en) 2009-11-20 2015-05-19 Sk Chemicals Co., Ltd. Gonadotropin releasing hormone receptor antagonist, preparation method thereof and pharmaceutical composition comprising the same
WO2011097553A1 (en) * 2010-02-08 2011-08-11 Allergan, Inc. Pyridazine derivatives useful as cannabinoid - 2 agonists
FR2969606B1 (fr) * 2010-12-22 2013-01-11 Pf Medicament Derives de diarylpyridazinones, leur preparation et leur application en therapeutique humaine
RU2455004C1 (ru) * 2011-04-01 2012-07-10 Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Ярославский государственный технический университет" (ФГБОУ ВПО "ЯГТУ") Способ получения сульфохлоридов ряда 6-арилпиридазин-3(2н)-онов

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1285235A (fr) * 1960-01-21 1962-02-23 Ciba Geigy Procédé de préparation de nouvelles diazines, notamment de 1-aryl-3-r-5-r'pyridazones-(6) dans lesquelles r représente un hydroxyle aliphatiquement éthérifié et r' représente un groupe n-(beta-aryl-éthyl)-pipérazino
US4088764A (en) * 1973-12-27 1978-05-09 Cassella Farbwerke Mainkur Aktiengesellschaft Pharmaceutically active derivatives of 1-phenoxy-3-amino-propan-2-ol
DE3048487A1 (de) * 1980-12-22 1982-07-29 Cassella Ag, 6000 Frankfurt Basisch substituierte pyridazine, ihre herstellung und ihre verwendung
JPH0641454B2 (ja) * 1985-02-27 1994-06-01 日産化学工業株式会社 ピリダジノン誘導体
EP0201765B1 (en) * 1985-04-27 1991-09-18 Nissan Chemical Industries Ltd. 3(2h)pyridazinone, process for its preparation and anti-allergic agent containing it
US4992433A (en) * 1987-11-23 1991-02-12 Janssen Pharmaceutica N.V. Novel pyridazinamine derivatives
MY104343A (en) * 1987-11-23 1994-03-31 Janssen Pharmaceutica Nv Novel pyridizinamine deravatives
US4992243A (en) * 1988-03-17 1991-02-12 Fedin Marat A Method of sterilizing anthers
IE62890B1 (en) * 1988-12-06 1995-03-08 Hafslund Nycomed Pharma New piperazinylalkyl-3(2h)-pyridazinones process for the preparation thereof and the use thereof as agents lowering blood pressure
DE3902316A1 (de) * 1989-01-26 1990-08-02 Lentia Gmbh Neue piperazinylalkyl-3(2h)-pyridazinone, verfahren zu ihrer herstellung und ihre verwendung als blutdrucksenkende mittel

Also Published As

Publication number Publication date
FI925807A0 (fi) 1992-12-21
HUT62865A (en) 1993-06-28
NL9202210A (nl) 1993-07-16
YU109292A (sr) 1996-01-09
GB2262526A (en) 1993-06-23
PL172933B1 (pl) 1997-12-31
CH684754A5 (de) 1994-12-15
AT403282B (de) 1997-12-29
ES2108595B1 (es) 1998-08-16
CA2085796C (en) 2000-08-08
HU214320B (hu) 1998-03-02
ES2108595A1 (es) 1997-12-16
GR1002281B (el) 1996-05-02
CZ380992A3 (en) 1993-09-15
DE4243381A1 (el) 1993-06-24
BE1006223A4 (fr) 1994-06-14
AU3031792A (en) 1993-06-24
DK152892D0 (da) 1992-12-21
DK152892A (da) 1993-06-21
JPH05255276A (ja) 1993-10-05
NL194966B (nl) 2003-05-01
RU2130019C1 (ru) 1999-05-10
KR100234596B1 (ko) 1999-12-15
YU48973B (sh) 2003-02-28
JP3165935B2 (ja) 2001-05-14
CZ286039B6 (cs) 1999-12-15
US5395934A (en) 1995-03-07
CN1088578A (zh) 1994-06-29
FR2685329B1 (fr) 1994-12-02
NL194966C (nl) 2003-09-02
FR2685329A1 (fr) 1993-06-25
FI925807A (fi) 1993-06-21
CA2085796A1 (en) 1993-06-21
GB2262526B (en) 1995-07-26
AU652304B2 (en) 1994-08-18
ATA253592A (de) 1997-05-15
GB9226601D0 (en) 1993-02-17
FI106374B (fi) 2001-01-31
GR920100570A (el) 1993-08-31
HU914057D0 (en) 1992-03-30
PL297070A1 (en) 1994-03-07
DE4243381B4 (de) 2005-07-28

Similar Documents

Publication Publication Date Title
HU9202848D0 (en) 1,2-dihydro-2-oxopyridine
HU9302460D0 (en) 5/20/4-(1,2-benzisothiazole-3-yl)-1-pierazinyl/ethyl/-6-chlorine-1,3-dihydro-2h-indole-2-one-hydrogen-chloride-mononhydrate
EP0569493A4 (en) Substituted 4,6-di-tertiary-butyl-5-hydroxy-pyrimidines
HU913050D0 (en) 1,3-benzoxasine derivatives, production and application thereof
HK19496A (en) Use of 1,2,2,3,3-penta-fluoropropane
ZA929903B (en) 3(2H)-pyridazinone derivatives and process for the preparation thereof.
GB2260135B (en) Substituted 2,6-diaminotoluenes
HUT57724A (en) Process for producing dialkyl-(2,3-pyridinedicarboxylate) and its derivatives
EP0544157A3 (en) Process for the preparation of 1,2-propyleneglycol
SG46741A1 (en) Pyridazinone derivatives and processes for preparing the same
GR3021203T3 (en) Process for the preparation of 1,1,1,2-tetrafluoro-2-chloroethan and pentafluorethane.
HUT66140A (en) New 2-spirocyclopropyl-cephalosporin-sulfone derivatives and process for the preparation thereof
PH29991A (en) Method for the preparation of 9-amino-1,2,3,4-tetrahydro-acridine
EP0542217A3 (en) Substituted 1,5-pentanediols and processes for the preparation thereof
HU908313D0 (en) New 15-nitro-2betha, 3betha-dihydro- and 15-nitro-2betha, 3 betha,6,7-tetrahydro-tabersonine derivatives
HU9301651D0 (en) Pyridyl-1,2,5-oxadiazole-carbonamide-2-oxide derivatives
EP0538686A3 (en) Process for the preparation of 2,2,-bis-hydroxymethyl-butanediol-(1,4)
AU652304C (en) 3(2H)-pyridazinone derivatives and process for the preparation thereof
GB2270313B (en) 1,3,4-Benzotriazepin-5 (4H)-one derivatives and process for the preparation thereof
HU9202296D0 (en) 3,4-dehydro-piperidine derivatives
EP0548640A3 (en) Process for the preparation of 2,4,5-triamino-6-halopyrimidines and 2-amino-6-halopurines
EP0479665A3 (en) 1,4-dihydropyridine derivatives, method for preparing the same and use thereof
IL100388A0 (en) Process for the preparation of 4-substituted 2,6-dialkylanilines
CS390590A3 (en) Substituted 5,15-diphenylporphyrins and process for preparing thereof
EP0683787A1 (en) 4'-O-SULFONYL-ANTHRACYCLINE DERIVATIVES.